These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26312146)

  • 1. Toll-like receptor activation: from renal inflammation to fibrosis.
    Yiu WH; Lin M; Tang SC
    Kidney Int Suppl (2011); 2014 Nov; 4(1):20-25. PubMed ID: 26312146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptors: sensing and reacting to diabetic injury in the kidney.
    Lin M; Tang SC
    Nephrol Dial Transplant; 2014 Apr; 29(4):746-54. PubMed ID: 24203812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptors and their role in renal pathologies.
    Eleftheriadis T; Pissas G; Liakopoulos V; Stefanidis I; Lawson BR
    Inflamm Allergy Drug Targets; 2012 Dec; 11(6):464-77. PubMed ID: 22931389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute kidney injury: what part do toll-like receptors play?
    Vallés PG; Lorenzo AG; Bocanegra V; Vallés R
    Int J Nephrol Renovasc Dis; 2014; 7():241-51. PubMed ID: 24971030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No difference in renal injury and fibrosis between wild-type and NOD1/NOD2 double knockout mice with chronic kidney disease induced by ureteral obstruction.
    Stroo I; Emal D; Butter LM; Teske GJ; Claessen N; Dessing MC; Girardin SE; Florquin S; Leemans JC
    BMC Nephrol; 2018 Apr; 19(1):78. PubMed ID: 29609537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors and kidney diseases.
    Eleftheriadis T; Lawson BR
    Inflamm Allergy Drug Targets; 2009 Jul; 8(3):191-201. PubMed ID: 19601879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous ligands for TLR2 and TLR4 are not involved in renal injury following ureteric obstruction.
    Chowdhury P; Sacks SH; Sheerin NS
    Nephron Exp Nephrol; 2010; 115(4):e122-30. PubMed ID: 20424490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The innate immune system, toll-like receptors and dermal wound healing: A review.
    Portou MJ; Baker D; Abraham D; Tsui J
    Vascul Pharmacol; 2015 Aug; 71():31-6. PubMed ID: 25869514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAGE and TLRs: relatives, friends or neighbours?
    Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
    Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling danger: toll-like receptors and their potential roles in kidney disease.
    Anders HJ; Banas B; Schlöndorff D
    J Am Soc Nephrol; 2004 Apr; 15(4):854-67. PubMed ID: 15034087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Toll-like receptors in diabetic nephropathy.
    Mudaliar H; Pollock C; Panchapakesan U
    Clin Sci (Lond); 2014 May; 126(10):685-94. PubMed ID: 24490813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifaceted roles of Toll-like receptors in acute kidney injury.
    Habib R
    Heliyon; 2021 Mar; 7(3):e06441. PubMed ID: 33732942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptors in hepatic ischemia/reperfusion and transplantation.
    Evankovich J; Billiar T; Tsung A
    Gastroenterol Res Pract; 2010; 2010():. PubMed ID: 20811615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immunity and Toll-like receptor signaling in the pathogenesis of scleroderma: advances and opportunities for therapy.
    Brown M; O'Reilly S
    Curr Opin Rheumatol; 2018 Nov; 30(6):600-605. PubMed ID: 30234721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor-4 signaling mediates inflammation and tissue injury in diabetic nephropathy.
    Garibotto G; Carta A; Picciotto D; Viazzi F; Verzola D
    J Nephrol; 2017 Dec; 30(6):719-727. PubMed ID: 28933050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases.
    Mohammad Hosseini A; Majidi J; Baradaran B; Yousefi M
    Adv Pharm Bull; 2015 Dec; 5(Suppl 1):605-14. PubMed ID: 26793605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll Like Receptors in systemic sclerosis: An emerging target.
    O'Reilly S
    Immunol Lett; 2018 Mar; 195():2-8. PubMed ID: 28888416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
    Cui J; Chen Y; Wang HY; Wang RF
    Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptors and cutaneous melanoma.
    Coati I; Miotto S; Zanetti I; Alaibac M
    Oncol Lett; 2016 Nov; 12(5):3655-3661. PubMed ID: 27900049
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.